TABLE 1.
hTERT expression and catalytic and biologic telomerase activity for the panel of N-terminal hTERT mutants
| Domain and mutanta | hTERT expression (105)b | Telomerase in vitro activityc | Life spand |
|---|---|---|---|
| Vector | 0.00001 | − | M |
| Wild type | 5 | ++ | I |
| I-A | |||
| +2 | 6 | + | S |
| +8 | 4 | − | M |
| +14 | 15 | + | S |
| +20 | 2 | − | M |
| +26 | 1 | − | M |
| +32 | 3 | ++ | S |
| +38 | 9 | +/− | M |
| +44 | 2 | +/− | M |
| +50f | 7 | − | M |
| +56 | 4 | − | M |
| +62 | 2 | ++ | I |
| DAT | |||
| +68 | 3 | ++ | M |
| +74 | 1 | + | M |
| +80 | 8 | + | M |
| +86 | 3 | ++ | S/M |
| +92 | 2 | ++ | M |
| +98 | 5 | ++ | M |
| +104 | 7 | ++ | S |
| +110 | 11 | ++ | S |
| +116 | 1 | ++ | S |
| +122 | 1 | ++ | M |
| +128 | 6 | ++ | M |
| I-B | |||
| +134 | 1 | +/− | M |
| +140 | 1 | +/− | M |
| +146 | 1 | +/− | M |
| +152f | 10 | − | M |
| +158 | 6 | − | M |
| +164 | 3 | − | M |
| +170 | 2 | − | M |
| L1 | |||
| +176 | 1 | ++ | I |
| +182 | 3 | ++ | I |
| +188 | 0.4 | ++ | I |
| +194 | 1 | ++ | I |
| +200 | 1 | ++ | I |
| +206 | 3 | ++ | I |
| +212 | 0.4 | ++ | I |
| +218 | 0.3 | ++ | I |
| +224 | 1 | ++ | I |
| +230 | 0.4 | ++ | I |
| +236 | 3 | ++ | I |
| +242 | 1 | ++ | I |
| +248 | 1 | ++ | I |
| +254 | 1 | ++ | I |
| +266 | 1 | ++ | I |
| +272 | 2 | ++ | I |
| +278 | 2 | ++ | I |
| +284 | 5 | ++ | I |
| +290 | 3 | ++ | I |
| +296 | 5 | ++ | I |
| +302 | 5 | ++ | I |
| +308 | 4 | ++ | I |
| +314 | 5 | ++ | I |
| +320 | 4 | ++ | I |
| +326 | 6 | + | I |
| +332 | 5 | + | I |
| +338 | 4 | ++ | I |
| +344 | 5 | ++ | I |
| II | |||
| +350 | 8 | +/− | S |
| +356 | 3 | − | M |
| +362 | 8 | +/− | S |
| +368 | 3 | ++ | I |
| +374 | 4 | ++ | I |
| +380 | 6 | +/− | M |
| +386e | 9 | − | M |
| +392 | 6 | − | M |
| +398 | 20 | + | S |
| +404 | 6 | − | M |
| L2 | |||
| +410 | 7 | ++ | I |
| +416 | 4 | ++ | I |
| +422 | 5 | ++ | I |
| +428 | 2 | ++ | I |
| +434 | 6 | ++ | I |
| +440 | 3 | ++ | I |
| III | |||
| +446 | 5 | +/− | M |
| +452 | 3 | − | M |
| +458 | 3 | +/− | M |
| +464 | 6 | − | M |
| +470 | 1 | − | M |
| +476 | 1 | − | M |
| +482 | 1 | − | M |
| +488 | 2 | +/− | M |
| +494 | 2 | − | M |
| +500 | 3 | ++ | I |
| +506 | 4 | +/− | M |
| +512e | 2 | − | M |
| +518 | 5 | +/− | M |
| +524 | 4 | ++ | I |
| +530 | 4 | − | M |
| +536 | 4 | − | M |
| +542 | 4 | − | M |
Each mutant is named after the starting position of the substitution in the native hTERT peptide sequence (i.e., +2 is 2PRAPRC to 2NAAIRS). Essential domains (I-A, I-B, II, and III), biologically essential domain (DAT), and nonessential linker regions (L1 and L2) are shown left of columns for mutant positions.
Fold overexpression of hTERT transcripts compared to vector control after samples were normalized for RNA content with the transcript level of the housekeeping gene PBGD.
In vitro telomerase activity for each mutant was determined by normalizing the activity to the internal standard and then expressed as a percentage of wild-type FLAG-hTERT activity as follows: ++ (>60%), + (60 to 15%), +/− (<15%), and − (extremely low or no detectable activity). At least two separate lysates were tested for each mutant.
Polyclonal HA5 cells overexpressing FLAG-hTERT mutants were serially passaged to determine the life span. Lifespan was defined by similarity to growth of vector (negative control) and wild-type FLAG-hTERT (positive control) cell lines. Mutants that grew like vector eventually underwent crisis and are termed M (mortal), mutants that continually divide at a rate similar to that of the wild-type FLAG-hTERT are termed I (immortal), and mutants that continually divide at a slower rate compared to that of the wild type are termed S (slow growth).
Mutants shown to have reduced hTR binding.
Mutants shown to have wild-type hTR binding.